Israeli Scientists Learn Why Most Metastatic Melanoma Patients Don’t Respond to Immunotherapy

Sheba Hospital in Tel Aviv. Israeli researchers at Tel Aviv University and Sheba Medical Center say they have discovered why more than half of patients with metastatic melanoma do not respond to immunotherapy cancer treatments. Wielding “proteomics” — an innovative “protein mapping” approach — a team of researchers led […]

Leave a Reply